Growth Metrics

Palisade Bio (PALI) Gains from Sales and Divestitures (2016 - 2023)

Palisade Bio (PALI) reported Gains from Sales and Divestitures of $34653.0 for Q3 2023, up 173.68% on a QoQ basis from $12662.0 in Q2 2023.

Palisade Bio (PALI) has 6 years of Gains from Sales and Divestitures data on file, last reported at $34653.0 in Q3 2023.

  • Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $34653.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $34653.0 (changed N/A YoY) and the FY2020 annual result came in at $3814.0, down 56.83% from the prior year.
  • Gains from Sales and Divestitures climbed to $34653.0 in Q3 2023 per PALI's latest filing, from $12662.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $34653.0 in Q3 2023 and bottomed at $3814.0 in Q4 2020.
  • The 3-year median for Gains from Sales and Divestitures is $8835.0 (2019), against an average of $13492.8.
  • The widest annual swing landed in 2019, when Gains from Sales and Divestitures slumped 87.81%; it then slumped 56.83% in 2020.
  • Tracing PALI's Gains from Sales and Divestitures over 3 years: stood at $8835.0 in 2019, then tumbled by 56.83% to $3814.0 in 2020, then soared by 808.57% to $34653.0 in 2023.
  • Per Business Quant, the three latest PALI Gains from Sales and Divestitures figures stand at $34653.0 (Q3 2023), $12662.0 (Q2 2023), and $3814.0 (Q4 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palisade Bio 439.25 Mn 309.68 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 34,653.00
Sep 30, 2023 34,653.00
Jun 30, 2023 12,662.00
Jun 30, 2023 12,662.00
Dec 31, 2020 3,814.00
Dec 31, 2020 3,814.00
Mar 31, 2020 7,500.00
Mar 31, 2020 7,500.00
Dec 31, 2019 8,835.00
Dec 31, 2019 8,835.00
Dec 31, 2018 72,483.00
Dec 31, 2018 72,483.00
Sep 30, 2018 25,000.00
Sep 30, 2018 25,000.00
Dec 31, 2017 29,869.00
Dec 31, 2017 29,869.00
Sep 30, 2017 13,000.00
Sep 30, 2017 13,000.00
Jun 30, 2017 1,924.00
Jun 30, 2017 1,924.00
Sep 30, 2016 213,904.00
Sep 30, 2016 213,904.00
Jun 30, 2016 213,904.00
Jun 30, 2016 213,904.00